BCPC
BALCHEM CORP
NASDAQ · Basic Materials · Chemicals - Specialty · US
$170.78
−0.49%Year over year
Reported trailing growth
- Revenue
- +10.1%
- EBITDA
- +10.9%
- EBIT
- +16.0%
- EPS
- +16.6%
- Free cash flow
- +11.9%
- Operating cash flow
- +17.2%
Forward estimates
Based on analyst estimates
- Revenue
- +9.7%
- EBITDA
- +4.8%
- EPS
- +5.4%
Three-year CAGR
- Revenue
- +3.2%
- EBITDA
- +9.2%
- EBIT
- +14.6%
- Net income
- +13.7%
- EPS
- +13.4%
- Free cash flow
- +25.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026